NANOIMMUNOTECH will be there attending partnering sessions and available in Spanish Pavilion (Booth 5315) to talk about Heatsens and Bioconjugation.NANOIMMUNOTECH is looking for partners for licensing out or co-develop their Heatsens technology for the detection of analytes in low concentrations. Their technology is characterized by greater specificity, greater sensitivity and reduced analysis time, resulting in higher flexibility and lower costs. These characteristics make Heatsens applicable to any sector needing to detect an analyte present in low concentration, such as clinical diagnostics, for example for cancer biomarkers, or food safety for the detection of pathogens and allergens.
NANOIMMUNOTECH is also an expert in oriented bioconjugation of any kind of biomolecule (antibodies, enzymes, DNA, RNA, small drugs, fluorophores…) to nanoparticles, surfaces or chips meaning higher specificity and sensitivity for your process. If you need to improve your immunoassay or point of care device sensitivity, their R&D department can give you advise on how to apply their nanoparticles or/and their oriented bioconjugation method.
Come and meet NANOIMMUNOTECH during the partnering sessions or in the commercial exhibition. They will be happy to have an exploratory discussion and talk about future collaborations.